Table of Content 1 Introduction 1.1 Objective of the Study 1.2 Definition of the Market 1.3 Market Scope 1.3.1 Market Segment by Type, Application and Marketing Channel 1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa) 1.4 Years Considered for the Study (2014-2026) 1.5 Currency Considered (U.S. Dollar) 1.6 Stakeholders 2 Key Findings of the Study 3 Market Dynamics 3.1 Driving Factors for this Market 3.2 Factors Challenging the Market 3.3 Opportunities of the Global Duchenne Muscular Dystrophy Therapeutics Market (Regions, Growing/Emerging Downstream Market Analysis) 3.4 Technological and Market Developments in the Duchenne Muscular Dystrophy Therapeutics Market 3.5 Industry News by Region 3.6 Regulatory Scenario by Region/Country 3.7 Market Investment Scenario Strategic Recommendations Analysis 4 Value Chain of the Duchenne Muscular Dystrophy Therapeutics Market 4.1 Value Chain Status 4.2 Upstream Raw Material Analysis 4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type) 4.4 Distributors/Traders 4.5 Downstream Major Customer Analysis (by Region) 5 Global Duchenne Muscular Dystrophy Therapeutics Market-Segmentation by Type 5.1 Pain Management Drugs 5.2 Corticosteroids 5.3 Prednisolone 5.4 Prednisone 5.5 Deflazacort 6 Global Duchenne Muscular Dystrophy Therapeutics Market-Segmentation by Application 6.1 Hospitals 6.2 Clinics 6.3 Home Care Settings 7 Global Duchenne Muscular Dystrophy Therapeutics Market-Segmentation by Marketing Channel 7.1 Traditional Marketing Channel (Offline) 7.2 Online Channel 8 Competitive Intelligence – Company Profiles 8.1 Marathon 8.1.1 Marathon Profile 8.1.2 Marathon Sales, Growth Rate and Global Market Share from 2014-2019E 8.1.3 Marathon Product/Solution Launches and Enhancements Analysis 8.1.4 Marathon Business Overview/Recent Development/Acquisitions 8.2 FibroGen 8.2.1 FibroGen Profile 8.2.2 FibroGen Sales, Growth Rate and Global Market Share from 2014-2019E 8.2.3 FibroGen Product/Solution Launches and Enhancements Analysis 8.2.4 FibroGen Business Overview/Recent Development/Acquisitions 8.3 ReveraGen BioPharma 8.3.1 ReveraGen BioPharma Profile 8.3.2 ReveraGen BioPharma Sales, Growth Rate and Global Market Share from 2014-2019E 8.3.3 ReveraGen BioPharma Product/Solution Launches and Enhancements Analysis 8.3.4 ReveraGen BioPharma Business Overview/Recent Development/Acquisitions 8.4 NS Pharma 8.4.1 NS Pharma Profile 8.4.2 NS Pharma Sales, Growth Rate and Global Market Share from 2014-2019E 8.4.3 NS Pharma Product/Solution Launches and Enhancements Analysis 8.4.4 NS Pharma Business Overview/Recent Development/Acquisitions 8.5 Italfarmaco 8.5.1 Italfarmaco Profile 8.5.2 Italfarmaco Sales, Growth Rate and Global Market Share from 2014-2019E 8.5.3 Italfarmaco Product/Solution Launches and Enhancements Analysis 8.5.4 Italfarmaco Business Overview/Recent Development/Acquisitions 8.6 Bristol-Myers Squibb 8.6.1 Bristol-Myers Squibb Profile 8.6.2 Bristol-Myers Squibb Sales, Growth Rate and Global Market Share from 2014-2019E 8.6.3 Bristol-Myers Squibb Product/Solution Launches and Enhancements Analysis 8.6.4 Bristol-Myers Squibb Business Overview/Recent Development/Acquisitions 8.7 PTC Therapeutics 8.7.1 PTC Therapeutics Profile 8.7.2 PTC Therapeutics Sales, Growth Rate and Global Market Share from 2014-2019E 8.7.3 PTC Therapeutics Product/Solution Launches and Enhancements Analysis 8.7.4 PTC Therapeutics Business Overview/Recent Development/Acquisitions 8.8 Santhera Pharmaceuticals 8.8.1 Santhera Pharmaceuticals Profile 8.8.2 Santhera Pharmaceuticals Sales, Growth Rate and Global Market Share from 2014-2019E 8.8.3 Santhera Pharmaceuticals Product/Solution Launches and Enhancements Analysis 8.8.4 Santhera Pharmaceuticals Business Overview/Recent Development/Acquisitions 8.9 Pfizer 8.9.1 Pfizer Profile 8.9.2 Pfizer Sales, Growth Rate and Global Market Share from 2014-2019E 8.9.3 Pfizer Product/Solution Launches and Enhancements Analysis 8.9.4 Pfizer Business Overview/Recent Development/Acquisitions 9 Global Duchenne Muscular Dystrophy Therapeutics Market-Segmentation by Geography 10 North America 10.1 North America Duchenne Muscular Dystrophy Therapeutics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 10.2 North America Duchenne Muscular Dystrophy Therapeutics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 10.3 North America Duchenne Muscular Dystrophy Therapeutics Production Analysis from 2014-2019E 10.4 North America Duchenne Muscular Dystrophy Therapeutics Consumption Analysis from 2014-2019E 10.5 North America Duchenne Muscular Dystrophy Therapeutics Import and Export from 2014-2019E 10.6 North America Duchenne Muscular Dystrophy Therapeutics Value, Production and Market Share by Type (2014-2019E) 10.7 North America Duchenne Muscular Dystrophy Therapeutics Consumption, Value and Market Share by Application (2014-2019E) 10.8 North America Duchenne Muscular Dystrophy Therapeutics by Country (United States, Canada) 10.8.1 North America Duchenne Muscular Dystrophy Therapeutics Sales by Country (2014-2019E) 10.8.2 North America Duchenne Muscular Dystrophy Therapeutics Consumption Value by Country (2014-2019E) 10.9 North America Duchenne Muscular Dystrophy Therapeutics Market PEST Analysis 11 Europe 11.1 Europe Duchenne Muscular Dystrophy Therapeutics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 11.2 Europe Duchenne Muscular Dystrophy Therapeutics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 11.3 Europe Duchenne Muscular Dystrophy Therapeutics Production Analysis from 2014-2019E 11.4 Europe Duchenne Muscular Dystrophy Therapeutics Consumption Analysis from 2014-2019E 11.5 Europe Duchenne Muscular Dystrophy Therapeutics Import and Export from 2014-2019E 11.6 Europe Duchenne Muscular Dystrophy Therapeutics Value, Production and Market Share by Type (2014-2019E) 11.7 Europe Duchenne Muscular Dystrophy Therapeutics Consumption, Value and Market Share by Application (2014-2019E) 11.8 Europe Duchenne Muscular Dystrophy Therapeutics by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium) 11.8.1 Europe Duchenne Muscular Dystrophy Therapeutics Sales by Country (2014-2019E) 11.8.2 Europe Duchenne Muscular Dystrophy Therapeutics Consumption Value by Country (2014-2019E) 11.9 Europe Duchenne Muscular Dystrophy Therapeutics Market PEST Analysis 12 Asia-Pacific 12.1 Asia-Pacific Duchenne Muscular Dystrophy Therapeutics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 12.2 Asia-Pacific Duchenne Muscular Dystrophy Therapeutics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 12.3 Asia-Pacific Duchenne Muscular Dystrophy Therapeutics Production Analysis from 2014-2019E 12.4 Asia-Pacific Duchenne Muscular Dystrophy Therapeutics Consumption Analysis from 2014-2019E 12.5 Asia-Pacific Duchenne Muscular Dystrophy Therapeutics Import and Export from 2014-2019E 12.6 Asia-Pacific Duchenne Muscular Dystrophy Therapeutics Value, Production and Market Share by Type (2014-2019E) 12.7 Asia-Pacific Duchenne Muscular Dystrophy Therapeutics Consumption, Value and Market Share by Application (2014-2019E) 12.8 Asia-Pacific Duchenne Muscular Dystrophy Therapeutics by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia) 12.8.1 Asia-Pacific Duchenne Muscular Dystrophy Therapeutics Sales by Country (2014-2019E) 12.8.2 Asia-Pacific Duchenne Muscular Dystrophy Therapeutics Consumption Value by Country (2014-2019E) 12.9 Asia-Pacific Duchenne Muscular Dystrophy Therapeutics Market PEST Analysis 13 Latin America 13.1 Latin America Duchenne Muscular Dystrophy Therapeutics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 13.2 Latin America Duchenne Muscular Dystrophy Therapeutics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 13.3 Latin America Duchenne Muscular Dystrophy Therapeutics Production Analysis from 2014-2019E 13.4 Latin America Duchenne Muscular Dystrophy Therapeutics Consumption Analysis from 2014-2019E 13.5 Latin America Duchenne Muscular Dystrophy Therapeutics Import and Export from 2014-2019E 13.6 Latin America Duchenne Muscular Dystrophy Therapeutics Value, Production and Market Share by Type (2014-2019E) 13.7 Latin America Duchenne Muscular Dystrophy Therapeutics Consumption, Value and Market Share by Application (2014-2019E) 13.8 Latin America Duchenne Muscular Dystrophy Therapeutics by Country (Brazil, Mexico, Argentina, Columbia, Chile) 13.8.1 Latin America Duchenne Muscular Dystrophy Therapeutics Sales by Country (2014-2019E) 13.8.2 Latin America Duchenne Muscular Dystrophy Therapeutics Consumption Value by Country (2014-2019E) 13.9 Latin America Duchenne Muscular Dystrophy Therapeutics Market PEST Analysis 14 Middle East & Africa 14.1 Middle East & Africa Duchenne Muscular Dystrophy Therapeutics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 14.2 Middle East & Africa Duchenne Muscular Dystrophy Therapeutics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 14.3 Middle East & Africa Duchenne Muscular Dystrophy Therapeutics Production Analysis from 2014-2019E 14.4 Middle East & Africa Duchenne Muscular Dystrophy Therapeutics Consumption Analysis from 2014-2019E 14.5 Middle East & Africa Duchenne Muscular Dystrophy Therapeutics Import and Export from 2014-2019E 14.6 Middle East & Africa Duchenne Muscular Dystrophy Therapeutics Value, Production and Market Share by Type (2014-2019E) 14.7 Middle East & Africa Duchenne Muscular Dystrophy Therapeutics Consumption, Value and Market Share by Application (2014-2019E) 14.8 Middle East & Africa Duchenne Muscular Dystrophy Therapeutics by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa) 14.8.1 Middle East & Africa Duchenne Muscular Dystrophy Therapeutics Sales by Country (2014-2019E) 14.8.2 Middle East & Africa Duchenne Muscular Dystrophy Therapeutics Consumption Value by Country (2014-2019E) 14.9 Middle East & Africa Duchenne Muscular Dystrophy Therapeutics Market PEST Analysis 15 Future Forecast of the Global Duchenne Muscular Dystrophy Therapeutics Market from 2018-2026 15.1 Future Forecast of the Global Duchenne Muscular Dystrophy Therapeutics Market from 2019-2026 Segment by Region 15.2 Global Duchenne Muscular Dystrophy Therapeutics Production and Growth Rate Forecast by Type (2019-2026) 15.3 Global Duchenne Muscular Dystrophy Therapeutics Consumption and Growth Rate Forecast by Application (2019-2026) 16 Appendix 16.1 Methodology 16.2 Research Data Source

List of Tables and Figures Global Duchenne Muscular Dystrophy Therapeutics Market Value ($) and Growth Rate of Duchenne Muscular Dystrophy Therapeutics from 2014-2026 Global Duchenne Muscular Dystrophy Therapeutics Production and Growth Rate Segment by Product Type from 2014-2026F Global Duchenne Muscular Dystrophy Therapeutics Consumption and Growth Rate Segment by Application from 2014-2019E Figure Duchenne Muscular Dystrophy Therapeutics Picture Table Product Specifications of Duchenne Muscular Dystrophy Therapeutics Table Driving Factors for this Market Table Industry News of Duchenne Muscular Dystrophy Therapeutics Market Figure Value Chain Status of Duchenne Muscular Dystrophy Therapeutics Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type) Table Distributors/Traders Table Downstream Major Customer Analysis (by Region, by Preference) Table Global Duchenne Muscular Dystrophy Therapeutics Production and Growth Rate Segment by Product Type from 2014-2019E Table Global Duchenne Muscular Dystrophy Therapeutics Value ($) and Growth Rate Segment by Product Type from 2014-2019E Figure Pain Management Drugs of Duchenne Muscular Dystrophy Therapeutics Figure Corticosteroids of Duchenne Muscular Dystrophy Therapeutics Figure Prednisolone of Duchenne Muscular Dystrophy Therapeutics Figure Prednisone of Duchenne Muscular Dystrophy Therapeutics Figure Deflazacort of Duchenne Muscular Dystrophy Therapeutics Table Global Duchenne Muscular Dystrophy Therapeutics Consumption and Growth Rate Segment by Application from 2014-2019E Table Global Duchenne Muscular Dystrophy Therapeutics Value ($) and Growth Rate Segment by Application from 2014-2019E Figure Hospitals of Duchenne Muscular Dystrophy Therapeutics Figure Clinics of Duchenne Muscular Dystrophy Therapeutics Figure Home Care Settings of Duchenne Muscular Dystrophy Therapeutics Table Global Duchenne Muscular Dystrophy Therapeutics Consumption and Growth Rate Segment by Marketing Channel from 2014-2019E Table Global Duchenne Muscular Dystrophy Therapeutics Value ($) and Growth Rate Segment by Marketing Channel from 2014-2019E Figure Traditional Marketing Channel (Offline) of Duchenne Muscular Dystrophy Therapeutics Figure Online Channel of Duchenne Muscular Dystrophy Therapeutics Table Marathon Profile (Company Name, Plants Distribution, Sales Region) Figure Marathon Sales and Growth Rate from 2014-2019E Figure Marathon Revenue ($) and Global Market Share from 2014-2019E Table Marathon Duchenne Muscular Dystrophy Therapeutics Sales, Price, Revenue, Gross Margin (2014-2019E) Table FibroGen Profile (Company Name, Plants Distribution, Sales Region) Figure FibroGen Sales and Growth Rate from 2014-2019E Figure FibroGen Revenue ($) and Global Market Share from 2014-2019E Table FibroGen Duchenne Muscular Dystrophy Therapeutics Sales, Price, Revenue, Gross Margin (2014-2019E) Table ReveraGen BioPharma Profile (Company Name, Plants Distribution, Sales Region) Figure ReveraGen BioPharma Sales and Growth Rate from 2014-2019E Figure ReveraGen BioPharma Revenue ($) and Global Market Share from 2014-2019E Table ReveraGen BioPharma Duchenne Muscular Dystrophy Therapeutics Sales, Price, Revenue, Gross Margin (2014-2019E) Table NS Pharma Profile (Company Name, Plants Distribution, Sales Region) Figure NS Pharma Sales and Growth Rate from 2014-2019E Figure NS Pharma Revenue ($) and Global Market Share from 2014-2019E Table NS Pharma Duchenne Muscular Dystrophy Therapeutics Sales, Price, Revenue, Gross Margin (2014-2019E) Table Italfarmaco Profile (Company Name, Plants Distribution, Sales Region) Figure Italfarmaco Sales and Growth Rate from 2014-2019E Figure Italfarmaco Revenue ($) and Global Market Share from 2014-2019E Table Italfarmaco Duchenne Muscular Dystrophy Therapeutics Sales, Price, Revenue, Gross Margin (2014-2019E) Table Bristol-Myers Squibb Profile (Company Name, Plants Distribution, Sales Region) Figure Bristol-Myers Squibb Sales and Growth Rate from 2014-2019E Figure Bristol-Myers Squibb Revenue ($) and Global Market Share from 2014-2019E Table Bristol-Myers Squibb Duchenne Muscular Dystrophy Therapeutics Sales, Price, Revenue, Gross Margin (2014-2019E) Table PTC Therapeutics Profile (Company Name, Plants Distribution, Sales Region) Figure PTC Therapeutics Sales and Growth Rate from 2014-2019E Figure PTC Therapeutics Revenue ($) and Global Market Share from 2014-2019E Table PTC Therapeutics Duchenne Muscular Dystrophy Therapeutics Sales, Price, Revenue, Gross Margin (2014-2019E) Table Santhera Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region) Figure Santhera Pharmaceuticals Sales and Growth Rate from 2014-2019E Figure Santhera Pharmaceuticals Revenue ($) and Global Market Share from 2014-2019E Table Santhera Pharmaceuticals Duchenne Muscular Dystrophy Therapeutics Sales, Price, Revenue, Gross Margin (2014-2019E) Table Pfizer Profile (Company Name, Plants Distribution, Sales Region) Figure Pfizer Sales and Growth Rate from 2014-2019E Figure Pfizer Revenue ($) and Global Market Share from 2014-2019E Table Pfizer Duchenne Muscular Dystrophy Therapeutics Sales, Price, Revenue, Gross Margin (2014-2019E) Table Global Duchenne Muscular Dystrophy Therapeutics Production Value ($) by Region from 2014-2019E Table Global Duchenne Muscular Dystrophy Therapeutics Production Value Share by Region from 2014-2019E Table Global Duchenne Muscular Dystrophy Therapeutics Production by Region from 2014-2019E Table Global Duchenne Muscular Dystrophy Therapeutics Consumption Value ($) by Region from 2014-2019E Table Global Duchenne Muscular Dystrophy Therapeutics Consumption by Region from 2014-2019E Table North America Duchenne Muscular Dystrophy Therapeutics Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table North America Duchenne Muscular Dystrophy Therapeutics Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table North America Duchenne Muscular Dystrophy Therapeutics Import and Export from 2014-2019E Table North America Duchenne Muscular Dystrophy Therapeutics Value ($) by Type (2014-2019E) Table North America Duchenne Muscular Dystrophy Therapeutics Production by Type (2014-2019E) Table North America Duchenne Muscular Dystrophy Therapeutics Consumption by Application (2014-2019E) Table North America Duchenne Muscular Dystrophy Therapeutics Consumption by Country (2014-2019E) Table North America Duchenne Muscular Dystrophy Therapeutics Consumption Value ($) by Country (2014-2019E) Figure North America Duchenne Muscular Dystrophy Therapeutics Market PEST Analysis Table Europe Duchenne Muscular Dystrophy Therapeutics Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Europe Duchenne Muscular Dystrophy Therapeutics Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Europe Duchenne Muscular Dystrophy Therapeutics Import and Export from 2014-2019E Table Europe Duchenne Muscular Dystrophy Therapeutics Value ($) by Type (2014-2019E) Table Europe Duchenne Muscular Dystrophy Therapeutics Production by Type (2014-2019E) Table Europe Duchenne Muscular Dystrophy Therapeutics Consumption by Application (2014-2019E) Table Europe Duchenne Muscular Dystrophy Therapeutics Consumption by Country (2014-2019E) Table Europe Duchenne Muscular Dystrophy Therapeutics Consumption Value ($) by Country (2014-2019E) Figure Europe Duchenne Muscular Dystrophy Therapeutics Market PEST Analysis Table Asia-Pacific Duchenne Muscular Dystrophy Therapeutics Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Asia-Pacific Duchenne Muscular Dystrophy Therapeutics Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Asia-Pacific Duchenne Muscular Dystrophy Therapeutics Import and Export from 2014-2019E Table Asia-Pacific Duchenne Muscular Dystrophy Therapeutics Value ($) by Type (2014-2019E) Table Asia-Pacific Duchenne Muscular Dystrophy Therapeutics Production by Type (2014-2019E) Table Asia-Pacific Duchenne Muscular Dystrophy Therapeutics Consumption by Application (2014-2019E) Table Asia-Pacific Duchenne Muscular Dystrophy Therapeutics Consumption by Country (2014-2019E) Table Asia-Pacific Duchenne Muscular Dystrophy Therapeutics Consumption Value ($) by Country (2014-2019E) Figure Asia-Pacific Duchenne Muscular Dystrophy Therapeutics Market PEST Analysis Table Latin America Duchenne Muscular Dystrophy Therapeutics Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Latin America Duchenne Muscular Dystrophy Therapeutics Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Latin America Duchenne Muscular Dystrophy Therapeutics Import and Export from 2014-2019E Table Latin America Duchenne Muscular Dystrophy Therapeutics Value ($) by Type (2014-2019E) Table Latin America Duchenne Muscular Dystrophy Therapeutics Production by Type (2014-2019E) Table Latin America Duchenne Muscular Dystrophy Therapeutics Consumption by Application (2014-2019E) Table Latin America Duchenne Muscular Dystrophy Therapeutics Consumption by Country (2014-2019E) Table Latin America Duchenne Muscular Dystrophy Therapeutics Consumption Value ($) by Country (2014-2019E) Figure Latin America Duchenne Muscular Dystrophy Therapeutics Market PEST Analysis Table Middle East & Africa Duchenne Muscular Dystrophy Therapeutics Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Middle East & Africa Duchenne Muscular Dystrophy Therapeutics Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Middle East & Africa Duchenne Muscular Dystrophy Therapeutics Import and Export from 2014-2019E Table Middle East & Africa Duchenne Muscular Dystrophy Therapeutics Value ($) by Type (2014-2019E) Table Middle East & Africa Duchenne Muscular Dystrophy Therapeutics Production by Type (2014-2019E) Table Middle East & Africa Duchenne Muscular Dystrophy Therapeutics Consumption by Application (2014-2019E) Table Middle East & Africa Duchenne Muscular Dystrophy Therapeutics Consumption by Country (2014-2019E) Table Middle East & Africa Duchenne Muscular Dystrophy Therapeutics Consumption Value ($) by Country (2014-2019E) Figure Middle East & Africa Duchenne Muscular Dystrophy Therapeutics Market PEST Analysis Table Global Duchenne Muscular Dystrophy Therapeutics Value ($) and Growth Rate Forecast by Region (2018-2026) Table Global Duchenne Muscular Dystrophy Therapeutics Production and Growth Rate Forecast by Region (2019-2026) Table Global Duchenne Muscular Dystrophy Therapeutics Consumption and Growth Rate Forecast by Region (2019-2026) Table Global Duchenne Muscular Dystrophy Therapeutics Production and Growth Rate Forecast by Type (2019-2026) Table Global Duchenne Muscular Dystrophy Therapeutics Consumption and Growth Rate Forecast by Application (2019-2026)